With growing awareness of the many roles played by vitamin D metabolites, testing volume is increasing
BY CRAIG FOREBACK, PHD
Vitamin D and its various forms are better characterized as hormones or prohormones rather than as a vitamin since the active form has many regulatory functions. An abundance of published clinical trials and epidemiological studies have contributed to the growing awareness of the many roles played by vitamin D metabolites. Vitamin D status is linked not only to classical targets such as bone, kidney, and intestine, but to an extensive diversity of tissues.1
Health care practitioners are now seeing the benefits of assessing vitamin D levels among patients of all ages and health statuses on a frequent basis. It is no surprise that there has been a surge of vitamin D testing in recent years (Figure 1). Likewise, the number of publications related to vitamin D testing has increased almost exponentially over the last 10 years (Figure 2).
This has led to the realization that an alarming number of people are vitamin D-deficient or have insufficient levels of vitamin D. Insufficient levels of vitamin D has been related to reduced immunological response, various forms of cancer, heart diseases, diabetes, rheumatoid arthritis, cognitive impairment, and overall mortality.2 One recent article reported an inverse relationship between epidemic influenza and solar radiation.3 The most recent newsletter from the Vitamin D Council (May 7, 2013)4 reviewed the research on multiple sclerosis (MS) and vitamin D. The link between when and where you were born and MS is well established. MS is more common in areas well north of the equator and in people born in early spring, suggesting that the amount of sunshine you get may be a risk factor for MS. Might this link be vitamin D-related?
The means by which vitamin D is judged is currently dependent on the accurate measurement of 25-hydroxy vitamin D, the precursor to 1,25-dihydroxyvitamin D, the active hormone. A myriad of methods are available, and there is considerable variation among them. Recently developed methods that measure 1,25-hydroxy vitamin D may improve the assessment process.
Vitamin D is a steroid-derived, fat-soluble vitamin. The vitamin and its metabolites exist in two forms: D2 and D3. Those identified as D2 are derived from yeast and plant material that has been irradiated with UVB light. It is available through supplementation and fortification of foods (eg, milk). D3 is found in foods and supplements, and it can be produced by the body. The vitamin and its metabolites are transported in the blood bound to vitamin D-binding protein (DBP). Although similar in structure, D2 derivatives have been reported to be 30% to 50% as active as D3 forms in the maintenance of serum 25-hydroxy vitamin D levels. However, some sources refute this claim.
Vitamin D is one of a few vitamins that can be produced by the body. Cutaneous 7-dehydrocholesterol undergoes photolysis to cholecalciferol when skin is exposed to UVB radiation. Twenty minutes of summer sunlight exposure can produce 20,000 units of Vitamin D3.5 The active form of vitamin D is produced by two sequential hydroxylations in the liver, then the kidneys (Figure 3). However, the latitude has a dramatic effect on this conversion. During the winter months at or above 35° N latitude, there is insufficient UVB to produce sufficient cholcalciferol to maintain adequate 25-hydroxy vitamin D. The vast majority (two-thirds) of residents in the continental United States and Alaska live at or above the above the 35th parallel. Because of the diminished sunlight from fall through early spring in most locales, increased intake of dietary vitamin D is critical. Fatty fish provides an excellent source. Fortified foods provide most of the vitamin D in the American diet, as there is modest consumption of foods naturally high in vitamin D. When UVB exposure is insufficient, supplementation is recommended.
Other factors can impact vitamin D levels, such as age, skin pigmentation, and skin covered by clothing or sunscreen. Even when adequate sunshine is obtained, such individuals will have insufficient levels of 25-hydroxy vitamin D. Recent studies have shown that three of every four Americans have deficient levels of vitamin D. As the appreciation of the critical functions of vitamin D metabolites grows, medical practitioners will be increasingly likely to see major benefits of testing patients to assess their vitamin D status.
TESTING FOR VITAMIN D
The first practical assay for vitamin D was a radioimmunoassay developed by DiaSorin, Saluggia, Italy, in 1985.6 The method had a minimum of simple, sample-handling steps, and was easy to automate. It compared favorably with high-performance liquid chromatography (HPLC) for the measurement of total vitamin D, but it was not able to discriminate between D2 and D3.
An HPLC method with UV detection that was less technically demanding and had lower costs than HPLC/MS/MS was developed at the University of Wisconsin Hospital and Clinics (UWHC) Laboratory, Madison, Wis, in 2005, and was reported in Clinical Chemistry by Lensmeyer et al.7 It is still in use at UWHC, although researchers are evaluating HPLC with tandem MS for the determination of 1,25-hydroxyvitamin D as well as several other vitamin D3 and D2 metabolites. The method can differentiate vitamin D2, D3, and C-3 epimer of 25-hydroxyvitamin D3, and it is effective for clinical evaluation of vitamin D levels in clinical settings. It has also been effectively transferred to two other laboratories.
Immunoassays are extensively used and have been the basis of large studies such as the National Health and Nutrition Examination Survey, the Harvard Nurses’ study, the Harvard Health Professions Study, and the Framingham Study. One large reference lab (LabCorp, Burlington, NC) employs an immunoassay for its routine 25-hydroxyvitamin D assay. Modern immunoassays use chemiluminescent labels for detection.
At least five different manufacturers have automated platforms with immunoassays for the testing of 25-hydroxy vitamin D, including Abbott, Abbott Park, Ill (ARCHITECT); DiaSorin Inc, with US headquarters in Stillwater, Minn (LIAISON); Roche, Indianapolis (Elecsys Systems); Siemens Healthcare (ADVIA Centaur); and Immunodiagnostic Systems Limited, UK (IDS-iSYS). Recent studies seeking to compare assays reported differences in the 25-OH vitamin D values observed across platforms and manufacturers.8,9 Today’s assays are required to measure both the vitamin D2 and D3 forms to accurately reflect total blood levels. This is particularly important for patients who are taking prescription supplements (which in some countries are in the form of vitamin D2) because a partial 25-OH vitamin D measurement could erroneously under-report therapeutic or even toxic circulating vitamin D levels.
Not all immunoassays recognize vitamin D2. It is important to choose an assay that has equal detection of vitamin D2 and D3 for routine clinical lab use. A recent report suggested that serum concentrations of vitamin D binding protein could cause bias of the reported vitamin D value by certain immunoassays.8 This report also found that certain immunoassays for some as yet unexplained reason under-report vitamin D levels in hemodialysis patients.
Isotope dilution-extraction tandem mass spectroscopy has created the opportunity for routine clinical laboratories to return to a rigorous method in which sample extraction, chromatography, and correction for procedural losses have been restored and specificity enhanced. LC/MS/MS is now widely used as the reference method in comparison studies and evaluation of a new method for vitamin D assays.
THE SAGA OF THE C-3 EPIMER OF 25-HYDROXYVITAMIN D3
As stated in the beginning of this article, measurement of circulating 25-hydroxyvitamin D has been subject to substantial laboratory and methodological variation. Recent assay improvements and the development of standards have enhanced agreement among laboratories and methods. Despite these advances, it remains that unappreciated factors continue to confound 25-hydroxyvitamin D measurements. The reported presence of the C-3 epimer of 25-hydroxyvitamin D3 in human serum10,11 is one such confounder. Some HPLC-MS/MS do not separate this metabolite, most likely due to inadequate run times.
It is widely believed that the C-3 epimer is only found in neonates, so the lack of separation of the two molecules with many LC/UV methods or LC/MS/MS methods was thought not to be a problem. Lensmeyer et al12 developed highly sensitive methods for the measurement of 3-epi 25 hydroxyvitamin D3 and established the presence of this isomer in adult serum. A recent report from Phenomenex Inc, Torrance, Calif,13 describes a method that provides excellent resolution of all on the monohydroxy D3 isomers, including the 3-epi within a short run time. In many patients the levels of this isomer are significant and can lead to an inappropriate determination of a patient’s vitamin D status.
The laboratory at UWHC is currently using LC/MS/MS to develop a method for the simultaneous separation and quantitation of a wide variety of vitamin D metabolites, including the C-3 epimer, 24,25-hydroxyvitamin D3 and D2, as well as the sulfated forms of the vitamin. According to Don Wiebe, PhD, technical director of clinical chemistry and toxicology, UWHC, the determination of total vitamin D levels alone will not be adequate for the assessment of a patient’s vitamin D status. He proposes that a panel of vitamin D metabolites may be necessary for at least the initial assessment of each patient and even for follow-up studies.
Craig Foreback, PhD, is a contributing writer for CLP. For more information, contact Editor Judy O’Rourke, [email protected]
1. Norman AW. From vitamin D to hormone D; Fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr. 2006;88;491S-499S.
2. Wiebe DA. Vitamin D methods: what’s all the fuss? 2013 ASCLS-WI Annual Meeting; April 24-25; Madison Wis.
3. Cannell JJ, Vieth R, Umhau JC, et al. Epidemic influenza and vitamin D. Epidemiol. Infect. 2006;134(6):1129-1140.
4.Vitamin D Council Newsletter, May 7, 2013. Available at: http//:www.vitamindcouncil.org. Accessed May 17, 2013.
5. Cannell JJ, Hollis BW. Use of vitamin D in clinical practice. Alt Med Rev. 2008;13:6-20.
6. Hollis BW, Napoli JL. Determination of vitamin D status by radioimmunoassay with an I 125 labeled tracer. Clin Chem. 1985;31(11):529-533.
7. Lensmeyer GL, Wiebe DA, Binkley N, Drezner MK. HPLC method for 25-hydroxyvitamin D measurement: Comparison with contemporary assays. Clin Chem. 2006;52(6):1120-1126.
8. Heijboer AC, Blankenstein MA, Kema IP, Buijs MM. Accuracy of 6 routine 25-hydroxyvitamin D assays: Influence of vitamin D binding protein concentration. Clin Chem. 2012;58:543-48.
9. Farrell CJL, Martin S, Mcwinnnney B, et al. State-of-the-art vitamin D assays: a comparison of automated immunoassays with liquid chromatography–tandem mass spectrometry methods. Clin Chem. 2012;58:531-543.
10. Schleicher RL, Encisco SE, Madhulika C-W, et al. Isotope dilution ultra performance liquid chromatography-tandem mass spectrometry for simultaneous measurement of 25-hydroxyvitamin D2, 25-hydroxyvitamin D3 and 3-epi-25-hydroxyvitamin D3 in human serum. Clin Chem Acta. 2011;412:1594-1599.
11. Strathmann FG, Sadilkova K, Laha TJ, et al. 3-epi-25 hydroxyvitamin D concentrations are not correlated with age in a cohort of infants and adults. Clin Chem Acta. 2012;413:203-206.
12. Lensmeyer G, Poquette M, Wiebe D, Binkley N. The C-3 Epimer of 25-hydroxyvitamin D3 is present in adult serum. J Clin Endocrinol Metab. 2012;97(1):163-168.
13. Sadjedi S, Layne J. Phenomenex Applications, Phenomenex Inc, Torrance, CA 90501, www.phenomenex.com.
CLICK HERE for a pdf of of a related journal article, co-authored by Marcel J.W. Janssen.
VITAMIN D TESTING PRODUCTS